Anchor Molecular

Anchor Molecular is a biotechnology startup founded in 2017 that focuses on providing Best-in-Class Quality Controls and Reference Materials for Molecular Testing. Specializing in reagents for molecular assays, the company aims to ensure more consistent, reliable, and accurate results for life-changing diagnostics. Particularly, Anchor Molecular's products target liquid biopsy cancer diagnostic tests based on cell-free DNA (cfDNA) and circulating tumor DNA (ctDNA). The company's mission is to deliver high-quality products for genetic testing at a cost that facilitates the accelerated adaptation of liquid biopsy testing worldwide. Currently, there is no available information on the company's headquarters, last investment, or the investors involved.